Dayspring Pharma Announces Phase II Trial of CG2001 Foam Met Primary Endpoint in Chinese Adult Men with AGA

B BEIJING, April 21, 2026 /PRNewswire/ — Dayspring Pharma today announced top-line data from its Phase II clinical trial of CG2001 foam in male patients with…
posteditor
posteditor
Articles: 21727

Other News